FDA Drug Recalls

Recalls / Class I

Class ID-0706-2021

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

FENTANYL-BUPIVACAINE HCL PF INJECTABLE 3000MCG-12MG/ML, 21 mL syringe, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605

Affected lot / code info
Lot #: 09302020@67 BUD: 10/29/2020

Why it was recalled

Non-Sterility

Recalling firm

Firm
Med Shop Total Care Inc.
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
470 E Loop 281, N/A, Longview, Texas 75605-7939

Distribution

Quantity
21 mL
Distribution pattern
Texas and Puerto Rico

Timeline

Recall initiated
2020-10-05
FDA classified
2021-08-09
Posted by FDA
2021-08-18
Terminated
2023-08-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0706-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class I recall: drug · FDA Drug Recalls